CARDIO ONCOLOGY IN THE ERA OF PRECISION MEDICINE

October 15, 2021

As new anti-cancer treatments enter the treatment arena, as a larger number of people are living longer with or after cancer, and as an aging population presents more often with co-morbidities at diagnosis, cardiovascular disease has emerged as a major cause of morbidity and mortality for cancer patients. In response, the field of cardio-oncology, an intersection between cardiology and oncology, has been established to strengthen the often complex and multifaceted care of the patient with both cancer and cardiology diagnoses. As valuable members of a multidisciplinary team, health care providers in primary care, oncology, and cardiology need to learn to assess, recognize, and manage cardiovascular risk factors and disease in patients with cancer.

Learning Objectives

• Discuss the role of precision medicine in the management of cardio-oncology diseases

• Understand risk stratification in cardio-oncology

• Discuss strategies for managing cardiovascular toxicities from antineoplastic therapies

• Discuss new developments in cardio-oncology

Course summary
Available credit: 
  • 4.00 ACPE - Pharmacist
  • 4.00 AMA PRA Category 1 Credit(s)
  • 4.00 ANCC
  • 4.00 Attendance
  • 4.00 JA Credit - AH
    • 4.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
10/15/2021
Registration Expires: 
10/14/2022
Activity Starts: 
10/15/2021 - 11:00am
Activity Ends: 
10/15/2021 - 5:30pm
Rating: 
0
Durham, NC 27705
United States

Available Credit

  • 4.00 ACPE - Pharmacist
  • 4.00 AMA PRA Category 1 Credit(s)
  • 4.00 ANCC
  • 4.00 Attendance
  • 4.00 JA Credit - AH
    • 4.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.